| 05/06/2026 8:04 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/06/2026 6:06 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 3:17 PM | Madrigal Pharmaceuticals (1157601) Filer | Form ARS | |
| 04/28/2026 3:05 PM | Madrigal Pharmaceuticals (1157601) Filer | Form DEF 14A | |
| 03/27/2026 9:34 AM | Madrigal Pharmaceuticals (1157601) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/06/2026 6:18 PM | Dier Mardi (1574591) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 5:58 PM | Dier Mardi (1574591) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 5:45 PM | Madrigal Pharmaceuticals (1157601) Subject Sibold William John (1518611) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 5:49 PM | Madrigal Pharmaceuticals (1157601) Issuer Sibold William John (1518611) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 5:34 PM | Kelley Shannon T (2034056) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 5:28 PM | Kelley Shannon T (2034056) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for MDGL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/06/2026 4:55 PM | Madrigal Pharmaceuticals (1157601) Issuer Soergel David (1591475) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 5:06 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 5:07 PM | Madrigal Pharmaceuticals (1157601) Issuer Taub Rebecca (1423898) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 5:12 PM | Huntsman Carole (2001571) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 5:15 PM | Huntsman Carole (2001571) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:31 PM | Dier Mardi (1574591) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 4:29 PM | Dier Mardi (1574591) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 4:32 PM | Dier Mardi (1574591) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 8:09 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/19/2026 6:05 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/26/2026 5:02 PM | Levy Richard S (1454983) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 4:38 PM | Huntsman Carole (2001571) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 4:35 PM | Huntsman Carole (2001571) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/26/2026 4:14 PM | Madrigal Pharmaceuticals (1157601) Issuer Sibold William John (1518611) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 4:02 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/26/2026 4:05 PM | Madrigal Pharmaceuticals (1157601) Issuer Taub Rebecca (1423898) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 4:11 PM | Madrigal Pharmaceuticals (1157601) Subject Sibold William John (1518611) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/26/2026 3:31 PM | Huntsman Carole (2001571) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/20/2026 4:54 PM | Kelley Shannon T (2034056) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/20/2026 4:58 PM | Kelley Shannon T (2034056) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 4:38 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/20/2026 4:46 PM | Madrigal Pharmaceuticals (1157601) Issuer Taub Rebecca (1423898) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 4:31 PM | Madrigal Pharmaceuticals (1157601) Issuer Thakkar Rita (2105550) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 4:22 PM | Madrigal Pharmaceuticals (1157601) Issuer Thakkar Rita (2105550) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/20/2026 3:39 PM | Kelley Shannon T (2034056) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/13/2026 3:38 PM | Madrigal Pharmaceuticals (1157601) Issuer Taub Rebecca (1423898) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:43 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:47 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:34 PM | Madrigal Pharmaceuticals (1157601) Issuer Taub Rebecca (1423898) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
| 12/12/2025 5:10 PM | FRIEDMAN PAUL A (1236927) Filed by Madrigal Pharmaceuticals (1157601) Subject | Form SCHEDULE 13D/A | |
| 12/12/2025 5:10 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Filed by | Form SCHEDULE 13D/A | |
| 12/12/2025 3:40 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 3:35 PM | Madrigal Pharmaceuticals (1157601) Issuer Taub Rebecca (1423898) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 3:15 PM | Madrigal Pharmaceuticals (1157601) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/10/2025 3:17 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/10/2025 3:17 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/04/2025 4:26 PM | Madrigal Pharmaceuticals (1157601) Issuer Sibold William John (1518611) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/04/2025 4:06 PM | Madrigal Pharmaceuticals (1157601) Subject Sibold William John (1518611) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/03/2025 4:59 PM | Dier Mardi (1574591) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/02/2025 3:23 PM | Dier Mardi (1574591) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/21/2025 4:39 PM | Huntsman Carole (2001571) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:26 PM | Huntsman Carole (2001571) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/14/2025 4:12 PM | Levy Richard S (1454983) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/07/2025 3:20 PM | BATE KENNETH (1210238) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2025 8:11 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2025 6:03 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:30 PM | Madrigal Pharmaceuticals (1157601) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 09/09/2025 8:24 PM | Madrigal Pharmaceuticals (1157601) Subject Sibold William John (1518611) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/09/2025 8:07 PM | Madrigal Pharmaceuticals (1157601) Issuer Sibold William John (1518611) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/29/2025 3:06 PM | CRAVES FRED B (1014095) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/21/2025 4:44 PM | Madrigal Pharmaceuticals (1157601) Issuer Sibold William John (1518611) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 3:24 PM | Madrigal Pharmaceuticals (1157601) Subject Sibold William John (1518611) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/20/2025 5:09 PM | 667, L.P. (1551139) Reporting Baker Bros. Advisors (0) GP BAKER BROS. ADVISORS LP (1263508) Reporting Baker Brothers Life Sciences LP (1363364) Reporting BAKER FELIX (1087940) Reporting BAKER JULIAN (1087939) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2025 5:12 PM | 667, L.P. (1551139) Reporting Baker Bros. Advisors (0) GP BAKER BROS. ADVISORS LP (1263508) Reporting Baker Brothers Life Sciences LP (1363364) Reporting BAKER FELIX (1087940) Reporting BAKER JULIAN (1087939) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2025 3:12 PM | CRAVES FRED B (1014095) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2025 4:30 PM | Kelley Shannon T (2034056) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2025 4:33 PM | Kelley Shannon T (2034056) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/15/2025 5:04 PM | BATE KENNETH (1210238) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/15/2025 4:34 PM | CRAVES FRED B (1014095) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/14/2025 10:24 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Madrigal Pharmaceuticals (1157601) Subject | Form SCHEDULE 13G/A | |
| 08/13/2025 5:18 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 4:33 PM | Madrigal Pharmaceuticals (1157601) Issuer Taub Rebecca (1423898) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 4:45 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 3:22 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/11/2025 3:26 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/11/2025 3:26 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/05/2025 6:17 PM | Brennan Daniel J. (1595612) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 08/05/2025 6:23 PM | Brennan Daniel J. (1595612) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:59 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2025 6:05 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/30/2025 5:30 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/22/2025 4:06 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/22/2025 4:08 PM | Madrigal Pharmaceuticals (1157601) Issuer Taub Rebecca (1423898) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/22/2025 7:29 AM | Madrigal Pharmaceuticals (1157601) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/18/2025 4:25 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/18/2025 4:03 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/17/2025 3:20 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/17/2025 3:21 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/16/2025 3:19 PM | Madrigal Pharmaceuticals (1157601) Subject Taub Rebecca (1423898) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
| 07/16/2025 3:20 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2025 3:45 PM | BATE KENNETH (1210238) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 3:30 PM | FRIEDMAN PAUL A (1236927) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 3:34 PM | Daly James M (1560782) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 3:38 PM | 667, L.P. (1551139) Reporting Baker Bros. Advisors (0) GP BAKER BROS. ADVISORS LP (1263508) Reporting Baker Brothers Life Sciences LP (1363364) Reporting BAKER FELIX (1087940) Reporting BAKER JULIAN (1087939) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 3:39 PM | FOUSE JACQUALYN A (1405288) Reporting Madrigal Pharmaceuticals (1157601) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 3:22 PM | Madrigal Pharmaceuticals (1157601) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/16/2025 5:23 PM | Madrigal Pharmaceuticals (1157601) Issuer Soergel David (1591475) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2025 11:15 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Madrigal Pharmaceuticals (1157601) Subject | Form SCHEDULE 13G/A | |